Generation of diversity in combinatorial libraries
CA 2279341 A1 · Owner: Rottgen, Peter · Inventors: Collins, John; Rottgen, Peter
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
The invention concerns gene banks and combinatorial derivatives thereof prepared using phagemid- or phage-display in combination with type IIS restriction enzymes and cosmid packaging; their use for the isolation of ligands, including enzyme inhibitors, agonists and antagonists for receptors competitive binding peptides to a defined target diagnostic ligands for , diseases and autoimmune syndromes including surveillance tools for immune status, post-translationally modified peptides and such ligands generated by , this technology.
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed February 2, 1998. No grant is recorded for it in Canada; had it been granted, its 20-year term would have ended February 2, 2018.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by February 2, 2020.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.